Watch live webcasts, procedural videos and more on Consult QD Live
A Q&A with Kris Adams
SGLT2 inhibitors already show heart benefits in diabetes patients
Reducing risk of recurrence 70%
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Reduces muscle pain caused by cholesterol-lowering drugs
Reduces incidence of infection by 40% compared to standard of care
Romosozumab builds more bone than any previous medication
FDA makes MitraClip available to more patients with mitral regurgitation
Tafamidis is first FDA-approved drug to treat potentially fatal disease
Reducing financial and other barriers to care
Advertisement
Advertisement